Growth Metrics

Oruka Therapeutics (ORKA) Assets (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Oruka Therapeutics 3.04 Bn 2.65 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.25%
Dec 31, 2025 -4.05%
Sep 30, 2025 42.48%
Jun 30, 2025 -5.22%
Mar 31, 2025 -4.77%
Dec 31, 2024 -4.36%
Sep 30, 2024 1,123.53%
Jun 30, 2024 -7.80%
Mar 31, 2024 -3.05%
Dec 31, 2023 -3.38%
Sep 30, 2023 -4.62%
Jun 30, 2023 -2.32%
Mar 31, 2023 -2.38%
Dec 31, 2022 -4.18%
Sep 30, 2022 -6.52%
Jun 30, 2022 -5.71%
Mar 31, 2022 -7.12%
Dec 31, 2021 -8.75%
Sep 30, 2021 -7.88%
Jun 30, 2021 -5.56%
Mar 31, 2021 37.19%
Dec 31, 2020 -2.99%
Sep 30, 2020 346.85%
Jun 30, 2020 55.92%
Mar 31, 2020 -12.59%
Dec 31, 2019 -14.20%
Sep 30, 2019 -4.23%
Jun 30, 2019 20.71%
Mar 31, 2019 26.10%
Dec 31, 2018 -19.18%
Sep 30, 2018 -16.11%
Jun 30, 2018 -21.28%
Mar 31, 2018 3.42%
Dec 31, 2017 -26.93%
Sep 30, 2017 -2.17%
Jun 30, 2017 -15.99%
Mar 31, 2017 -16.40%
Dec 31, 2016 -14.12%
Sep 30, 2016 -12.12%
Jun 30, 2016 -11.63%
Mar 31, 2016 -6.69%
Dec 31, 2015 -6.66%
Sep 30, 2015 -6.02%
Jun 30, 2015 240.21%
Mar 31, 2015 -17.80%
Dec 31, 2014 -10.57%
Sep 30, 2014 -12.18%
Jun 30, 2014 -9.34%
Mar 31, 2014 32.61%
Dec 31, 2013 -10.73%
Sep 30, 2013 -7.92%
Jun 30, 2013 402.13%
Mar 31, 2013 28.86%
Dec 31, 2012 -7.22%
Sep 30, 2012 -9.28%
Jun 30, 2012 -23.03%
Mar 31, 2012 -23.75%
Dec 31, 2011 0.06%
Sep 30, 2011 -24.27%